News

WRF gifts $2M to ISB to advance P4 Medicine

PRESS RELEASE from Washington Research Foundation:

Sept. 30, 2015, Seattle –– Washington Research Foundation (WRF), which supports groundbreaking technology in the life sciences, physical sciences and information sciences in Washington State, announced today that it will provide the Institute for Systems Biology (ISB) with $2 million in funding to bring increased research power to Seattle, and help place this community at the center of the coming transformation of the health care
system. The funding will help accelerate ISB’s P4 biomedical research, which is catalyzing a new industry – scientific wellness – and establish Seattle as its epicenter. P4 medicine is predictive, preventive,
personalized and participatory and has two central thrusts – quantifying wellness and demystifying disease. The current healthcare industry focuses 98 percent of its efforts and resources on addressing disease. In contrast, P4 medicine will enable the quantification of wellness and promises a revolution in the healthcare system – from a focus on disease to a focus on wellness. This has the potential to save the healthcare systems billions of dollars.

Read full press release…

Recent Articles

  • The Aging Microbiome

    Gut Microbiome Implicated in Healthy Aging and Longevity

    The gut microbiome is an integral component of the body, but its importance in the human aging process is unclear. ISB researchers and their collaborators have identified distinct signatures in the gut microbiome that are associated with either healthy or unhealthy aging trajectories, which in turn predict survival in a population of older individuals.

  • Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

    NIAID Director Dr. Anthony Fauci sat down for a conversation with ISB’s Dr. Lee Hood. The renowned scientists spoke about the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19, lessons learned from the COVID-19 pandemic, and much more.

  • Priyanka Baloni

    Bile Acids Provide More Evidence of the Gut Microbiome’s Effect on Alzheimer’s Disease

    ISB researchers and their collaborators are looking beyond the one-drug, one-solution approach that has thus far failed in Alzheimer’s disease research. Instead, they are focusing on other promising research avenues, such as the possible role of the gut microbiome in dementia.